BACKGROUND: Colorectal cancer (CRC) is one of the leading cause of cancer deaths
worldwide. The aetiology of CRC is complex and involves interaction on environmental and …

Colorectal cancer (CRC) is one of the most common malignant cancers worldwide and
seriously threatens human health. The clustered regulatory interspaced short palindromic …

The accumulation of various genetic and epigenetic changes in colonic epithelial cells has
been identified as one of the fundamental processes that drive the initiation and progression …

Colorectal cancer (CRC) is one of the most prevalent digestive tumors in China. Recent
studies indicate that long intergenic non-coding RNAs (lincRNAs) play a crucial role in …

Colorectal cancer treatment has undergone a paradigm shift. We no longer see this disease
as a singular, anatomic tumor type but rather a set of disease subgroups. Largely because of …

Colorectal cancer (CRC) is the second leading cause of cancer-related deaths in the United
States. Despite ongoing efforts aimed at increasing screening for CRC and early detection …

The benefit of adjuvant chemotherapy in the early stages of colorectal cancer (CRC) is still
disappointing and the prediction of treatment outcome quite difficult. Recently, through a …

Patients with BRAF‐mutated colorectal cancer (CRC) have a poor prognosis despite recent
therapeutic advances such as combination therapy with BRAF, MEK, and epidermal growth …

Colorectal cancer is one of the leading malignancies and still accounts for almost 25 000
deaths in Germany each year. Although there is accumulating data on the molecular basis …

Background Cancer metabolism is largely altered compared to normal cells. This study aims
to explore critical metabolism pathways in colon adenocarcinoma (COAD), and reveal the …